No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT)

Articolo

Data di Pubblicazione:

2014

Citazione:

Sainato, A., Cernusco Luna Nunzia, V., Valentini, V., De Paoli, A., Maurizi, E., Lupattelli, M., Aristei, C., Vidali, C., Conti, M., Galardi, A., Ponticelli, P., Friso, M., Iannone, T., Osti, F., Manfredi, B., Coppola, M., Orlandini, C., Cionini, L., No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT), <>, 2014; 113 (2): 223-229. [doi:10.1016/j.radonc.2014.10.006] [http://hdl.handle.net/10807/63792]

Abstract:

To evaluate the effect of adjuvant chemotherapy (ACT) in locally advanced rectal cancer (LARC) after neoadjuvant chemoradiation (NACT-RT). The study was funded by the Italian National Research Council (CNR).

Tipologia CRIS:

Articolo in rivista, Nota a sentenza

Keywords:

Adjuvant chemotherapy; Preoperative radiochemotherapy; Rectal cancer

Elenco autori: